Medicus Pharma (NASDAQ:MDCX – Get Free Report) announced its quarterly earnings results on Friday. The company reported ($0.18) EPS for the quarter, beating analysts’ consensus estimates of ($0.32) by $0.14, Zacks reports.
Medicus Pharma Price Performance
Shares of NASDAQ:MDCX opened at $3.13 on Friday. Medicus Pharma has a 12-month low of $1.80 and a 12-month high of $6.00. The stock’s fifty day moving average is $3.21.
Wall Street Analyst Weigh In
Several research firms have commented on MDCX. Maxim Group began coverage on Medicus Pharma in a research report on Tuesday, December 17th. They issued a “buy” rating and a $10.00 target price for the company. Brookline Capital Management upgraded shares of Medicus Pharma to a “strong-buy” rating in a report on Monday, December 23rd.
Medicus Pharma Company Profile
Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.
Featured Stories
- Five stocks we like better than Medicus Pharma
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- The Role Economic Reports Play in a Successful Investment Strategy
- MarketBeat Week in Review – 03/24 – 03/28
- Top Stocks Investing in 5G Technology
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
